Interesting Neuro: Staging Alzheimer & TBI Findings

Our August news includes a potential classification system for Alzheimer disease, new findings in a 3D model of TBI, and migraine treatments.

We present a selection of interesting neurology articles for the month of August in the following slides. See the slide legends for links to the article summaries.

Related Videos
Related Content

Neuro News Roundup: TBI Awareness Month

March 31st 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

Raising Awareness on Traumatic Brain Injury and Significance of Abbott’s Approved Alinity i Lab-Based Blood Test

March 31st 2023

Episode 83: The ARISE Study and Using DMTs in RIS

February 24th 2023

Blarcamesine Deemed Safe, Effective in Phase 2 Extension Study of Parkinson Disease Dementia

March 30th 2023

Tiziana Announces Planned Phase 2 Study of Foralumab in Progressive Multiple Sclerosis

March 29th 2023

Neuro News Roundup: TBI Awareness Month

March 31st 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

Raising Awareness on Traumatic Brain Injury and Significance of Abbott’s Approved Alinity i Lab-Based Blood Test

March 31st 2023

Episode 83: The ARISE Study and Using DMTs in RIS

February 24th 2023

Blarcamesine Deemed Safe, Effective in Phase 2 Extension Study of Parkinson Disease Dementia

March 30th 2023

Tiziana Announces Planned Phase 2 Study of Foralumab in Progressive Multiple Sclerosis

March 29th 2023

Neuro News Roundup: TBI Awareness Month

March 31st 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

Raising Awareness on Traumatic Brain Injury and Significance of Abbott’s Approved Alinity i Lab-Based Blood Test

March 31st 2023

Episode 83: The ARISE Study and Using DMTs in RIS

February 24th 2023

Blarcamesine Deemed Safe, Effective in Phase 2 Extension Study of Parkinson Disease Dementia

March 30th 2023

Tiziana Announces Planned Phase 2 Study of Foralumab in Progressive Multiple Sclerosis

March 29th 2023
© 2023 MJH Life Sciences

All rights reserved.